Boston to distribute CorTrak's products:
This article was originally published in Clinica
Executive Summary
Boston Scientific will exclusively distribute the coronary iontophoresis drug delivery products which are being developed by CorTrak Medical. Boston has also made an unspecified equity investment in CorTrak, which is based in Minneapolis. The CorTrak system is in pre-clinical studies and uses a catheter and an electric field to transport drugs through difficult tissue barriers and into cells. Initially, the company will focus on treating and preventing problems associated with coronary angioplasty.